PRNewsWire - Health

QBIOTICS REPORTS 80% OBJECTIVE RESPONSE RATE IN INJECTED TUMOURS IN STAGE 1 OF PHASE IIA CLINICAL TRIAL OF TIGILANOL TIGLATE FOR SOFT TISSUE SARCOMA
UFE Doesn't Remove Fibroids--Here's What Women Aren't Being Told
Nékter Juice Bar Kicks Off Summer with Tropical-Inspired Pineapple Whip Collection
Curve Therapeutics Co-Founder and CSO Professor Ali Tavassoli awarded the Royal Society of Chemistry's Interdisciplinary Prize